Lactulose
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lactulose and local guidelines before prescribing.
Osmotic laxative
Mechanism
Osmotic laxative; acidifies colonic contents reducing ammonia absorption.
Uses
Constipation, hepatic encephalopathy.
Dosing
- Lactulose (e.g. 15–30 mL two to three times daily), titrated to 2–3 soft stools a day . Phosphate enemas if the patient cannot swallow.
Gastroenterology: Gastroenterology Emergencies (Complete) - Lactulose Hepatic encephalopathy | e.g. 15–30 mL two to three times daily, titrated to 2–3 soft stools a day.
Gastroenterology: Gastroenterology Emergencies (Complete) - Lactulose , titrated to 2–3 soft stools a day (e.g. 15–30 mL twice daily).
Gastroenterology: Cirrhosis and Transplantation - Rifaximin 550 mg twice daily (NICE TA337) - added after a further episode of overt HE despite lactulose. Reduces hospital admissions.
Gastroenterology: Cirrhosis and Transplantation
2 more dose entries from the chapters
- Rifaximin 550 mg twice daily | Recurrent overt HE despite lactulose (NICE TA337).
Gastroenterology: Cirrhosis and Transplantation - Add rifaximin 550 mg twice daily to lactulose.
Gastroenterology: Cirrhosis and Transplantation
Side effects
Bloating, flatulence, cramps, diarrhoea.
Interactions
Few.
Contraindications and cautions
Intestinal obstruction, galactosaemia
Monitoring
Stool frequency
Pregnancy and breastfeeding
Safe
Renal and hepatic impairment
No adjustment
Overdose and reversal
Fluids
Special advice
Titrate to 2–3 soft stools daily in hepatic encephalopathy; takes 48 hours to work for constipation.
More from the textbook: uses, cautions and other points
- Osmotic | Macrogol (polyethylene glycol), lactulose , magnesium salts, phosphate enemas | Hold water in the bowel | Macrogol - first-line in many; faecal impaction (high dose). Lactulose - bloating and wind; used in hepatic encephalopathy. Magnesium - avoid in CKD
Gastroenterology: Anatomy Physiology Pharmacology - Laxatives for IBS with constipation (avoid lactulose - causes bloating); linaclotide if others fail.
Gastroenterology: Anatomy Physiology Pharmacology - Lactulose - first-line for hepatic encephalopathy : osmotic laxative that also acidifies the colon , trapping ammonia as ammonium (not absorbed) and reducing ammonia-making bacteria; aim for 2–3 soft stools a day (avoid dehydration and low sodium from over-use). Phosphate enemas if unable to take orally.
Gastroenterology: Anatomy Physiology Pharmacology - Hepatic encephalopathy: lactulose, rifaximin, find the precipitant; avoid sedatives and opioids.
Gastroenterology: Anatomy Physiology Pharmacology - Osmotic - unabsorbed substances pull water in (lactose intolerance, magnesium, lactulose, sorbitol, malabsorption) - stops when fasting ; raised stool osmotic gap.
Gastroenterology: Anatomy Physiology Pharmacology - Rifaximin - poorly absorbed antibiotic; added to lactulose to prevent recurrent hepatic encephalopathy (NICE TA337).
Gastroenterology: Anatomy Physiology Pharmacology - Lactulose | Osmotic; hepatic encephalopathy -2–3 soft stools a day.
Gastroenterology: Anatomy Physiology Pharmacology - Rifaximin | With lactulose to prevent recurrent hepatic encephalopathy.
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (10 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (8 mentions)
- Gastroenterology: Investigations (1 mention)
- Gastroenterology: Bowel Disorders (3 mentions)
- Gastroenterology: Cirrhosis and Transplantation (8 mentions)
- Paediatrics: Gastroenterology and surgery in children (2 mentions)
- Obstetrics (1 mention)
- Obstetrics: Post Natal Care (1 mention)
- Medicine of the older adult: Continence, nutrition, skin and other geriatric syndromes (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Integrated paediatrics chapter (2 mentions)
- Biochemistry: Metabolism of carbohydrates, lipids and proteins (1 mention)